German drug and chemicals company Bayer AG announced Monday that it has made a $62 billion offer to buy U.S.-based crops and seeds specialist Monsanto. The proposed combination would create a giant seed and farm chemical company with a strong presence in the U.S., Europe and Asia. Bayer said the all-cash offer values shares of Monsanto at $122 each. That compares with a closing price Friday of $101.52 and is 37 percent higher than the closing price of $89.03 on May 9, the day before Bayer made a written proposal to Monsanto. Bayer had said on Thursday that its executives met recently with their Monsanto counterparts “to privately discuss a negotiated acquisition” of the specialist in genetically modified crop seeds, which is headquartered in St. Louis, Missouri. Monsanto said then that it was reviewing Bayer’s proposal. Bayer said it plans to finance the acquisition with a combination of debt and equity. It said that it “is prepared to proceed immediately to due diligence and negotiations and to quickly agree to a transaction.” “Monsanto is a perfect match to our agricultural business,” Bayer CEO Werner Baumann said in a video message posted on his company’s website. “We would combine complementary skills with minimal geographic overlap.” Monsanto is now entering the world of pharmaceuticals by an accusation of one of the worlds biggest drug companies. We could now see even drugs and the ingredients that make them be turned into Genetically Modified Organisms. As if side effects from drugs weren't already bad enough, just wait till these drugs start being genetically modified by Monsanto. Two things that poison the world's population are now coming together in the form of now GMO drugs.
Anti msm news, Created by a US NAVY vet. "Seek the truth" Check me out on Facebook and Twitter at top of page, also check me out on gab.ai @PuppetStringNews